Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pancreatic Neoplasms 153Carcinoma, Non-Small-Cell Lung 94Neoplasms 57Breast Neoplasms 50Urinary Bladder Neoplasms 47Neoplasm Metastasis 43Lung Neoplasms 41Ovarian Neoplasms 36Cholangiocarcinoma 31Lymphoma 20Sarcoma 19Gallbladder Neoplasms 19Fallopian Tube Neoplasms 19Lymphoma, Large B-Cell, Diffuse 18Biliary Tract Neoplasms 18Recurrence 15Lymphoma, Non-Hodgkin 15Adenocarcinoma 14Hodgkin Disease 13Carcinoma, Transitional Cell 13Bile Duct Neoplasms 13Carcinoma 12Colorectal Neoplasms 10Head and Neck Neoplasms 8Carcinoma, Renal Cell 8Urethral Neoplasms 7Parkinson Disease 4, Autosomal Dominant Lewy Body 7Carcinoma, Ovarian Epithelial 7Adenocarcinoma of Lung 7Uterine Cervical Neoplasms 6

Interventions

Ifosfamide 10Carboplatin 8Paclitaxel 7Etoposide 7Filgrastim 5Dexamethasone 3Cisplatin 3Thiotepa 2Stem Cell Transplantation 2Peripheral Blood Stem Cell Transplantation 2Oxaliplatin 2Ondansetron 2Mesna 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Cyclophosphamide 2Calcium Dobesilate 2Bleomycin 2Aprepitant 2tremelimumab 1thymoglobulin 1sodium thiosulfate 1poly ICLC 1pembrolizumab 1pegfilgrastim 1palifosfamide lysine 1palbociclib 1isophosphamide mustard 1fosaprepitant 1etoposide phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Testicular Neoplasms × Gemcitabine × Clear all
NCT00936936 2024-08-26

High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors

M.D. Anderson Cancer Center

Phase 2 Completed
64 enrolled 10 charts
Genitourinary

Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡